Publications

Export 47 results:
Sort by: Author Title Type [ Year (Desc)]
2019
El Sharkawi FZ, Ali SA, Hegazy MI, Atya HB. The combined effect of IL-17F and CCL20 gene polymorphism in susceptibility to multiple sclerosis in Egypt.. 2019;685:164-9. Abstract
n/a
El Sharkawi FZ, Ali SA HM. The combined effect of IL-17F and CCL20 gene polymorphism in susceptibility to multiple sclerosis in Egypt.. 2019;685. Abstract
n/a
Collaborators GB. Global, regional, and national burden of neurological disorders, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.. 2019;18(5). Abstract
n/a
Collaborators GB. Global, regional, and national burden of stroke, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016.. 2019;18(5). Abstract
n/a
2018
of Collaborators TG. Global, Regional, and Country-Specific Lifetime Risks of Stroke, 1990 and 2016.. 2018;379(25). Abstract
n/a
Collaborators GB. Global, regional, and national age-sex-specific mortality and life expectancy, 1950–2017: a systematic analysis for the Global Burden of Disease Study 2017.. 2018;392(10159):1684-735. Abstract
n/a
Collaborators GB. Global, regional, and national age-sex-specific mortality and life expectancy, 1950–2017: a systematic analysis for the Global Burden of Disease Study 2017.. 2018;392(10159). Abstract
n/a
Collaborators GB. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017.. 2018;392(10159):1736-88. Abstract
n/a
of Collaborators GB. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017.. 2018;392(10159). Abstract
n/a
Collaborators GB. Global, regional, and national burden of migraine and tension-type headache, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016.. 2018;17(11):954-76. Abstract
n/a
Collaborators GB. Global, regional, and national burden of Parkinson's disease, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016.. 2018;17(11):939-53. Abstract
n/a
and Collaborators GB. Global, regional, and national burden of traumatic brain injury and spinal cord injury, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.. 2018;18(1). Abstract
n/a
and Collaborators GB. Measuring performance on the Healthcare Access and Quality Index for 195 countries and territories and selected subnational locations: a systematic analysis from the Global Burden of Disease Study 2016.. 2018;391(10136):2236-71. Abstract
n/a
Collaborators GB. Measuring progress from 1990 to 2017 and projecting attainment to 2030 of the health-related Sustainable Development Goals for 195 countries and territories: a systematic analysis for the Global Burden of Disease Study 2017.. 2018;392(10159):2091-138. Abstract
n/a
Collaborators GB. Measuring progress from 1990 to 2017 and projecting attainment to 2030 of the health-related Sustainable Development Goals for 195 countries and territories: a systematic analysis for the Global Burden of Disease Study 2017.. 2018;392(10159). Abstract
n/a
Hamdy SM, Abdel-Naseer M, Shalaby NM, Elmazny A, Girgis M, Nada MA, et al. Pediatric-onset multiple sclerosis in egypt: a multi-center registry of 186 patients.. 2018;14:631. Abstract
n/a
and Collaborators GB. Population and fertility by age and sex for 195 countries and territories, 1950–2017: a systematic analysis for the Global Burden of Disease Study 2017.. 2018;392(10159):1995-2051. Abstract
n/a
and Collaborators GB. Population and fertility by age and sex for 195 countries and territories, 1950–2017: a systematic analysis for the Global Burden of Disease Study 2017.. 2018;392(10159). Abstract
n/a
A. Hassan, M. Farghaly HH. Testing of Verbal Fluency in Egyptians: Cultural and Educational Challenges.. 2018;31(3):133-41. Abstract
n/a
Atya HB, Ali SA, Hegazy MI, El Sharkawi FZ. Urinary Urea, Uric Acid and Hippuric Acid as Potential Biomarkers in Multiple Sclerosis Patients.. 2018;33(2):163-70. Abstract
n/a
2017
Hamdy SM, Abdel-Naseer M, Shalaby NM, Elmazny AN, Nemr AA, Hassan A, et al. characteristics and predictors of progression in an egyptian multiple sclerosis cohort: a multicenter registry study. Neuropsychiatric disease and treatment. 2017;13:1895. Abstract
n/a
Atya HB, Ali SA, Hegazy MI, El Sharkawi FZ. Is rs763780 in IL-17F gene considered risk factor to multiple sclerosis in Egyptian patients? Meta Gene. 2017;14:124-8. Abstract
n/a
Fouad MM, Farag SM, Hegazy MI, Aziz MA. Prediction of Functional Outcome in Ischemic Stroke Patients: An Observational Study on Egyptian Population. Cureus. 2017;9(6). Abstract
n/a
Atya HB, Ali SA, Hegazy MI, El Sharkawi FZ. Urinary Urea, Uric Acid and Hippuric Acid as Potential Biomarkers in Multiple Sclerosis Patients. Indian Journal of Clinical Biochemistry. 2017:1-8. Abstract
n/a
2016
Eissa EM, Daker LI, Shaban MM, Hegazy MI. Lumbar puncture as a single modality for treatment of idiopathic intracranial hypertension during pregnancy. The Egyptian Journal of Neurology, Psychiatry and Neurosurgery. 2016;53(1):33-6. Abstract
n/a
Tourism